AFX-300 series (Aphoenix)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAFX-300 series (Aphoenix)
Drug Alias Namemacrolide derivatives (Aphoenix)AFX-301AFX-358
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPsoriasisCystitis, InterstitialRespiratory Tract Diseases +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAphoenix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAphoenix Inc
Active IndicationsN/A
Inactive IndicationsPsoriasisCystitis, InterstitialRespiratory Tract Diseases +[6] 

Other Information

ATC CodeN/A
Related LinksN/A